Ethyl 2'-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)-2-(ethoxymethyl)-[1,1'-biphenyl]-4-carboxylate, identified by its CAS number 1247868-68-3, is a complex organic compound characterized by its unique structural features. It contains a biphenyl core, which is a common motif in organic chemistry, known for its stability and ability to participate in various chemical reactions. The presence of a sulfamoyl group indicates potential biological activity, as sulfamoyl derivatives are often explored for their pharmacological properties. Additionally, the isoxazole ring contributes to the compound's electronic properties, potentially enhancing its reactivity and interaction with biological targets. The ethyl and methoxymethyl substituents suggest that the compound may exhibit lipophilicity, which can influence its solubility and permeability in biological systems. Overall, this compound's intricate structure suggests it may have applications in medicinal chemistry, particularly in the development of new therapeutic agents. However, specific biological activity and safety profiles would require further investigation through experimental studies.

ethyl 2'-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)-2-(ethoxymethyl)-[1,1'-biphenyl]-4-carboxylate

1247868-68-3: Ethyl 2'-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)-2-(ethoxymethyl)-[1,1'-biphenyl]-4-carboxylate, identified by its CAS number 1247868-68-3, is a complex organic compound characterized by its unique structural features. It contains a biphenyl core, which is a common motif in organic chemistry, known for its stability and ability to participate in various chemical reactions. The presence of a sulfamoyl group indicates potential biological activity, as sulfamoyl derivatives are often explored for their pharmacological properties. Additionally, the isoxazole ring contributes to the compound's electronic properties, potentially enhancing its reactivity and interaction with biological targets. The ethyl and methoxymethyl substituents suggest that the compound may exhibit lipophilicity, which can influence its solubility and permeability in biological systems. Overall, this compound's intricate structure suggests it may have applications in medicinal chemistry, particularly in the development of new therapeutic agents. However, specific biological activity and safety profiles would require further investigation through experimental studies.

CAS 1247868-68-3

ethyl 2'-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)-2-(ethoxymethyl)-[1,1'-biphenyl]-4-carboxylate

Sparsentan Ester Impurity

Ref: ST-EA-CP-S178003